Medylife Global FZE, intends to have the following Action Plans of implementation to achieve the goals and objectives​

Continue To Expand And Diversify The Product Portfolio.

The company intends to continue to expand and diversify its existing product offerings in order to cater to different therapeutic segments in pharma chemicals-related products and specialty chemicals. Presently, the Company has a strong bonded relationship with the contract manufacturers.

The Company believes in harnessing the fruits of science for goals that go beyond business. The company wants to be a market leader in Active Pharmaceutical raw material to enjoy a dominant position in lifesaving anti-cancer drugs & cutting-edge technology.

Further, as a part of its business strategy, the company will also cover important therapeutic segments such as pain management, erectile dysfunction and hormone replacement therapy, anti-obesity amongst others with a focus to offer a wider product portfolio to its existing customer base which will enable the company to be present in the entire value chain of its products leading to cost, quality and time control and customization thereby improving the margins and increase in customer satisfaction.

The Company aims to enter into a contract manufacturer who holds a license from the Food and Drug Administration of the respective countries for the manufacture of liquids, lozenges, and ointments. In addition to this, the company will be outsourcing the products in tablet and capsule dosage form for various therapeutic segments like irregular bowel movement, insomnia, stress management, smoking de-addiction, appetite enhancer, natural immunity booster, etc from various companies.

Focus on increasing the market share for lifestyle and high valued drugs:

The Company has been supplying APIs to international markets and has established relationships with its clients. However, going further the company intends to enter into lifestyle and value drugs due to better margins in various therapeutic segments namely, hormone replacement therapy, anti-obesity, and oncology, etc 

These products have large markets worldwide. Based on the company’s internal management estimates, these products are manufactured by limited companies for the global markets. The company plans to focus its sales and marketing efforts on these product groups to capture larger market shares.

Establish the presence in international markets

The company already established its presence in the international markets and will expand further into the European market the company believes that demand for its products in these markets will continue to grow in line with changes in healthcare standards, insurance penetration, and most of the countries’ government spending on healthcare. Increased sales in such countries would allow the company to achieve economies of scale. The company plans to establish its presence in these markets by product registrations and filings and by increasing its customer base through marketing arrangements with local pharmaceutical companies.

Leaders of the pure Trade movement

The company leadership credo – “Do until done” is not just a business mantra but a movement towards better and inspiring ideas. Perseverance is a part of the Company’s culture and it lives it every day. The impact of this philosophy can be felt in every aspect of business and workplaces. It fuels the company’s pursuit of excellence and inspires to push for better ideas and outcomes. It drives the team to constantly improve their business practices by adopting innovative processes and practical solutions that allow them to win in every scenario.

Patent and Trade Mark

The company has also been looking at future investments in acquiring patents so that it can funnel exponential growth as the world moves towards a more regulated regime. At the same time, we shall maintain our dedication towards producing world-class products at affordable prices benefitting mankind.

As a dynamic company, Medylife Global FZE recognizes that its success depends on its ability to grow; therefore, the company has been pursuing investment opportunities, particularly in the pharma sector, which allows the company to optimally use the knowledge and experience available in-house within the company.

The success story of the Company for its sustainable growth, stability, and credibility in the international business, is the Company’s clear vision of Risk mitigation process that put into the system that is carried by the entire teamwork with true spirit.